ELK4
Basic information
Region (hg38): 1:205597556-205632011
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ELK4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 19 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 1 | 0 |
Variants in ELK4
This is a list of pathogenic ClinVar variants found in the ELK4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
1-205599173-G-A | not specified | Uncertain significance (Jul 06, 2021) | ||
1-205599225-A-G | not specified | Uncertain significance (Jun 18, 2021) | ||
1-205616626-T-A | not specified | Uncertain significance (Aug 30, 2021) | ||
1-205619003-G-A | not specified | Uncertain significance (Oct 21, 2024) | ||
1-205619067-T-A | not specified | Uncertain significance (Apr 20, 2024) | ||
1-205619997-G-A | not specified | Uncertain significance (Jul 12, 2023) | ||
1-205620000-G-C | not specified | Uncertain significance (Sep 16, 2021) | ||
1-205620007-A-G | not specified | Uncertain significance (Dec 19, 2022) | ||
1-205620078-T-C | not specified | Uncertain significance (May 31, 2023) | ||
1-205620081-G-C | not specified | Uncertain significance (Apr 19, 2023) | ||
1-205620162-T-C | not specified | Uncertain significance (Sep 30, 2024) | ||
1-205620176-C-T | not specified | Uncertain significance (Oct 08, 2024) | ||
1-205620180-G-C | not specified | Uncertain significance (Jul 11, 2022) | ||
1-205620187-A-G | not specified | Uncertain significance (Sep 06, 2022) | ||
1-205620195-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
1-205620268-G-T | not specified | Uncertain significance (Dec 07, 2021) | ||
1-205620271-G-A | not specified | Likely benign (Aug 27, 2024) | ||
1-205620307-T-C | not specified | Likely benign (May 27, 2022) | ||
1-205620327-G-A | not specified | Uncertain significance (Sep 17, 2021) | ||
1-205620402-G-C | not specified | Uncertain significance (Jan 03, 2024) | ||
1-205620405-A-G | not specified | Uncertain significance (Aug 15, 2023) | ||
1-205620406-T-C | not specified | Uncertain significance (May 01, 2024) | ||
1-205620477-T-C | not specified | Uncertain significance (Jul 25, 2023) | ||
1-205620523-G-T | not specified | Uncertain significance (Dec 02, 2024) | ||
1-205620570-T-C | not specified | Uncertain significance (Jan 23, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ELK4 | protein_coding | protein_coding | ENST00000357992 | 4 | 24020 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00341 | 0.956 | 125734 | 0 | 14 | 125748 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.482 | 202 | 222 | 0.909 | 0.0000108 | 2805 |
Missense in Polyphen | 54 | 81.212 | 0.66492 | 1017 | ||
Synonymous | -0.000434 | 86 | 86.0 | 1.00 | 0.00000425 | 906 |
Loss of Function | 1.79 | 6 | 12.9 | 0.464 | 6.37e-7 | 176 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000578 | 0.0000578 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000548 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000886 | 0.0000879 |
Middle Eastern | 0.0000548 | 0.0000544 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Involved in both transcriptional activation and repression. Interaction with SIRT7 leads to recruitment and stabilization of SIRT7 at promoters, followed by deacetylation of histone H3 at 'Lys-18' (H3K18Ac) and subsequent transcription repression. Forms a ternary complex with the serum response factor (SRF). Requires DNA-bound SRF for ternary complex formation and makes extensive DNA contacts to the 5'side of SRF, but does not bind DNA autonomously. {ECO:0000269|PubMed:22722849}.;
- Pathway
- HTLV-I infection - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);Transcriptional misregulation in cancer - Homo sapiens (human);EGF-Core;Mesodermal Commitment Pathway;MAPK Signaling Pathway;EGF-EGFR Signaling Pathway;ID signaling pathway;Serotonin HTR1 Group and FOS Pathway;Serotonin Receptor 2 and ELK-SRF-GATA4 signaling;Serotonin Receptor 4-6-7 and NR3C Signaling;FGF;PDGF;ID;Signaling mediated by p38-alpha and p38-beta
(Consensus)
Recessive Scores
- pRec
- 0.0959
Intolerance Scores
- loftool
- 0.542
- rvis_EVS
- -0.4
- rvis_percentile_EVS
- 26.53
Haploinsufficiency Scores
- pHI
- 0.974
- hipred
- Y
- hipred_score
- 0.766
- ghis
- 0.660
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 1.00
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Elk4
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); hematopoietic system phenotype; vision/eye phenotype; immune system phenotype; homeostasis/metabolism phenotype; skeleton phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype;
Gene ontology
- Biological process
- negative regulation of transcription by RNA polymerase II;regulation of transcription by RNA polymerase II;cell differentiation;positive regulation of transcription by RNA polymerase II;histone H3 deacetylation
- Cellular component
- nucleus;nucleoplasm;cytosol
- Molecular function
- RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;core promoter binding;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;chromatin binding;DNA-binding transcription factor activity;transcription coregulator activity;protein binding